IHC News and Research

RSS
New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

Combination of MET and erlotinib delays lung cancer progression: Study

Combination of MET and erlotinib delays lung cancer progression: Study

Triple-negative breast cancer patients may have unique biomarker to receive targeted therapy: Research

Triple-negative breast cancer patients may have unique biomarker to receive targeted therapy: Research

New disposable, microfluidic PDMS device for identification of advanced breast cancer

New disposable, microfluidic PDMS device for identification of advanced breast cancer

Miltenyi Biotec releases ACSA-1 MicroBead Kit to isolate GLAST-expressing astrocytes

Miltenyi Biotec releases ACSA-1 MicroBead Kit to isolate GLAST-expressing astrocytes

20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors

20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

ACD launches RNAscope Formalin-Fixed, Paraffin-Embedded Assay Kit

ACD launches RNAscope Formalin-Fixed, Paraffin-Embedded Assay Kit

Epitomics launches EP Clone Rabbit Monoclonal Antibodies

Epitomics launches EP Clone Rabbit Monoclonal Antibodies

Affymetrix launches QuantiGene ViewRNA Assay formats

Affymetrix launches QuantiGene ViewRNA Assay formats

LSBio announces exclusive distribution agreements with select strategic partners

LSBio announces exclusive distribution agreements with select strategic partners

TLR4 may provide new strategy for treating patients with PDAC: Study

TLR4 may provide new strategy for treating patients with PDAC: Study

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Pelvic extraperitoneal IMT with malignant transformation in 14-year-old

Pelvic extraperitoneal IMT with malignant transformation in 14-year-old

New guideline to improve IHC testing for expression status of ER and PgR in breast cancer issued

New guideline to improve IHC testing for expression status of ER and PgR in breast cancer issued

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

Dartmouth-Hitchcock Medical Center to implement BioImagene's digital pathology solutions

Dartmouth-Hitchcock Medical Center to implement BioImagene's digital pathology solutions

Quintiles announces comprehensive suite of PI3K biomarker assays

Quintiles announces comprehensive suite of PI3K biomarker assays

Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting

Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting